尤瑞克林联合羟乙基淀粉注射液治疗分水岭脑梗死的临床疗效

Clinical effect of urinarykallid combined with hydroxyethylstarch on cerebral watershed infarction

目的分析尤瑞克林联合羟乙基淀粉注射液治疗分水岭脑梗死患者急性期和远期的临床治疗效果。方法选取2014年2月至2015年6月分水岭脑梗死患者80例为研究对象，采用随机数表法将其分为观察组和对照组，每组各40例，两组患者均给予稳压、降糖、抗血小板聚集等常规治疗，对照组患者在此基础上加用羟乙基淀粉注射液，观察组患者给予尤瑞克林联合羟乙基淀粉注射液，比较两组患者急性期和远期的临床效果。结果治疗后14d，观察组患者日常生活能力和神经功能恢复均明显优于对照组（P〈0．05）；治疗后3个月，观察组患者神经功能及日常生活能力恢复均明显优于对照组，且治疗总有效率明显高于对照组（P〈0．01）。结论尤瑞克林联合羟乙基淀粉注射液在治疗分水岭脑梗死患者急性期和远期均有较好的临床治疗效果。

Objective To analyze the clinical effect of urinarykallid combined with hydroxyeth- ylstarch on cerebral watershed infarction in acute phase and forward. Methods Eighty patients with cerebral watershed infarction from February 2014 to June 2015 were selected. All the patients were randomly divided into the observation group and the control group, with 40 cases in each group, the two groups were treated with blood pressure decreasing, blood glucosem reducing, anti-platelet aggregation and other conventional drugs, the control group was treated with hydroxyethy, and the observation group was treated with urinarykallid combined with hydroxyethy starch, the clinical effects of acute and long-term of the two groups were compared. Results After 14 days treament, the activity of daily living and neurological recovery of observation group were significantly better than those of the control group （P 〈 0. 05 ） ; 3 months after treatment, the total efficiency of observation group was significantly higher than that of control group （ P 〈 0. 01 ）. Conclusions Urinarykallid combined with hydroxyethyl starch in the treatment of cerebral watershed infarction has better clinical efficacy in acute phase and forward.